|
May 15
|
Here’s Why Baron Discovery Fund Sold Repligen Corporation (RGEN)
|
|
May 10
|
We Discuss Why Repligen Corporation's (NASDAQ:RGEN) CEO Compensation May Be Closely Reviewed
|
|
May 7
|
Repligen Corporation to Present at Upcoming May Investor Conferences
|
|
May 3
|
Repligen First Quarter 2024 Earnings: EPS Misses Expectations
|
|
May 2
|
Repligen Corporation (NASDAQ:RGEN) Q1 2024 Earnings Call Transcript
|
|
May 2
|
Repligen (RGEN) Q1 Earnings Miss, Revenues Beat Estimates
|
|
May 2
|
Repligen Corp (RGEN) Q1 2024 Earnings Call Transcript Highlights: Navigating Market Shifts and ...
|
|
May 1
|
Repligen Corp (RGEN) Q1 2024 Earnings: A Close Alignment with Analyst Projections
|
|
May 1
|
Repligen (RGEN) Misses Q1 Earnings Estimates
|
|
May 1
|
Repligen Reports First Quarter 2024 Financial Results
|
|
Apr 23
|
Should be Confident in Repligen Corporation (RGEN)’s Long-Term Growth Potential?
|
|
Apr 17
|
Repligen to Report First Quarter 2024 Financial Results
|
|
Apr 12
|
Artisan Mid Cap Fund Trimmed Repligen Corporation (RGEN) after Share Appreciation
|
|
Mar 19
|
Repligen Appoints Maggie A. Pax to Board of Directors
|
|
Mar 18
|
Are Repligen Corporation's (NASDAQ:RGEN) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
|
|
Mar 12
|
Repligen Corp CEO Anthony Hunt Sells 16,707 Shares
|
|
Mar 4
|
PBYI vs. RGEN: Which Stock Is the Better Value Option?
|
|
Jan 8
|
Is Repligen Corporation (NASDAQ:RGEN) Potentially Undervalued?
|
|
Dec 19
|
Repligen Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference
|
|
Dec 18
|
Here’s Why Repligen Corporation (RGEN) Rose 13% in Q3
|